Loading clinical trials...
Loading clinical trials...
An Open-label, Multicenter, Phase Ib Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects Aged 2 to 17 Years With Atopic Dermatitis
Conditions
Interventions
Experimental: B244
Locations
6
United States
Dermatology Trial Associates
Bryant, Arkansas, United States
L.A. Universal Research Center, Inc.
Los Angeles, California, United States
The Indiana Clinical Trials Center
Plainfield, Indiana, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Skin Specialists, PC
Omaha, Nebraska, United States
Virginia Clinical Research, INC
Norfolk, Virginia, United States
Start Date
December 7, 2018
Primary Completion Date
May 18, 2019
Completion Date
June 10, 2019
Last Updated
August 5, 2024
NCT07262983
NCT06389136
NCT06342713
NCT07290803
NCT07223697
NCT07265479
Lead Sponsor
AOBiome LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions